🔎 Trials Near Me

Dachaigh › Myeloma iomaill › Maryland › Baltimore

Sgrùdaidhean clionaigeach Myeloma iomaill ann an Baltimore, MD

Tha 13 sgrùdaidhean airson Myeloma iomaill a’ lorg phàirtichean aig làraichean ann agus timcheall air Baltimore (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

A’ fastadhÌre 1 tràth
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06398457

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

A’ fastadhÌre 3
  • University of Maryland School of Medicine, Baltimore
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07258511

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

A’ fastadhÌre 3
  • Johns Hopkins Hospital, Baltimore
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07518186

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

A’ fastadhÌre 3
  • Johns Hopkins University School of Medicine JHUSOM, Baltimore
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT05552222

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

A’ fastadhÌre 3
  • Johns Hopkins Asthma & Allergy Center, Baltimore
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT07648264

Collection of Tissue Samples for Cancer Research

A’ fastadhSgrùdadh amharc
  • Johns Hopkins University, Baltimore
2 Months · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT00900198

A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma

A’ fastadhÌre 3
  • University of Maryland | Greenebaum Cancer Center, Baltimore
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT06980480

Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT

A’ fastadhÌre 3
  • Research Site, Baltimore
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Lùna 2026 · NCT07764978

A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects

A’ fastadhÌre 1
  • University of Maryland Greenbaum Comprehensive Cancer Center, Baltimore
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 12 Lùna 2026 · NCT07280013

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

A’ fastadhÌre 3
  • Greater Baltimore Medical Center, Baltimore
Gach aois · Gach gnè · Air ùrachadh 10 Ògmh 2026 · NCT05561387

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

A’ fastadhÌre 3
  • Greenebaum Cancer Center UM of MD, Baltimore
  • John Hopkins, Baltimore
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Ògmh 2026 · NCT05243797

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

A’ fastadhÌre 1/2
  • Sibley Memorial Hospital, Baltimore
  • University of Maryland, Baltimore
  • Johns Hopkins Main Center, Baltimore
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 24 Màrt 2026 · NCT04988555

A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma

A’ fastadhÌre 1/2
  • Johns Hopkins Medicine - The Sidney Kimmel Comprehensive Cancer Center, Baltimore
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Sult 2025 · NCT05372354

Sgrùdaidhean Myeloma iomaill ann am bailtean eile

Sgrùdaidhean eile ann an Baltimore

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.